← back to search

Jinhai Deng

Guangdong Pharmaceutical University · CN
Area of research
Pulmonary and Respiratory Medicine · Molecular Biology
Research interest
Research interests include Ferroptosis and cancer prognosis, Epigenetics and DNA Methylation, Immune cells in cancer, and MicroRNA in disease regulation.
h-index
18
citations
969
works
96
NIH funding
primary concept
email

Recent publications

Copper in cancer: friend or foe? Metabolism, dysregulation, and therapeutic opportunities
Cancer Communications 2025cited by 26position: middledoi
PAM-Independent CRISPR-Cas12a System for Specific Assays of Single Nucleotide Variants
JACS Au 2025cited by 22position: middledoi
THBS2-producing matrix CAFs promote colorectal cancer progression and link to poor prognosis via the CD47-MAPK axis
Cell Reports 2025cited by 20position: middledoi
FOS-driven inflammatory CAFs promote colorectal cancer liver metastasis via the SFRP1-FGFR2-HIF1 axis
Theranostics 2025cited by 15position: middledoi
Efficient discovery of robust prognostic biomarkers and signatures in solid tumors
Cancer Letters 2025cited by 10position: middledoi
Genome-wide nucleosome footprints of plasma cfDNA predict preterm birth: A case-control study
PLoS Medicine 2025cited by 8position: middledoi
ScarElastic: continuous elasticity field modeling for myocardial scar delineation in LGE-CMR
npj Digital Medicine 2025cited by 1position: middledoi
THBS2 + cancer-associated fibroblasts promote EMT leading to oxaliplatin resistance via COL8A1-mediated PI3K/AKT activation in colorectal cancer
Molecular Cancer 2024cited by 71position: middledoi
The MondoA-dependent TXNIP/GDF15 axis predicts oxaliplatin response in colorectal adenocarcinomas
EMBO Molecular Medicine 2024cited by 5position: firstdoi
Non-volatile double-tunable vortex metalens design based on Sb2S3 using deep neural network and particle swarm optimization algorithm
Optics Communications 2024cited by 4position: middledoi
Comprehensive Analysis of Tertiary Lymphoid Structures in Pancreatic Cancer: Molecular Characteristics and Prognostic Implications
Current Proteomics 2024cited by 2position: lastdoi
The role of TXNIP in cancer: a fine balance between redox, metabolic, and immunological tumor control
British Journal of Cancer 2023cited by 69position: firstdoi
Ampere-hour-scale soft-package potassium-ion hybrid capacitors enabling 6-minute fast-charging
Nature Communications 2023cited by 50position: middledoi
Exosomal transfer leads to chemoresistance through oxidative phosphorylation-mediated stemness phenotype in colorectal cancer
Theranostics 2023cited by 37position: firstdoi
The difference in the composition of gut microbiota is greater among bats of different phylogenies than among those with different dietary habits
Frontiers in Microbiology 2023cited by 5position: middledoi
Identification and validation of immunotherapy for four novel clusters of colorectal cancer based on the tumor microenvironment
Frontiers in Immunology 2022cited by 57position: middledoi
Exosomal transfer of miR-181b-5p confers senescence-mediated doxorubicin resistance via modulating BCLAF1 in breast cancer
British Journal of Cancer 2022cited by 46position: middledoi
Boric Acid‐Assisted Pyrolysis for High‐Loading Single‐Atom Catalysts to Boost Oxygen Reduction Reaction in Zn‐Air Batteries
Energy & environment materials 2022cited by 41position: middledoi
Smooth muscle cell fate decisions decipher a high-resolution heterogeneity within atherosclerosis molecular subtypes
Journal of Translational Medicine 2022cited by 34position: middledoi
Epigenetic Signaling of Cancer Stem Cells During Inflammation
Frontiers in Cell and Developmental Biology 2021cited by 54position: middledoi
C1Q/TNF-related protein 4 expression correlates with herpes simplex encephalitis progression
Annals of Translational Medicine 2019cited by 10position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Zaoqu Liu · Zhengzhou University7 papers (2021–2025)Siyuan Weng · Zhengzhou University5 papers (2022–2025)Yuhao Ba · Zhengzhou University5 papers (2024–2025)Long Liu · Binzhou Medical University4 papers (2022–2025)Quan Cheng · Central South University4 papers (2024–2025)Huanxin Li · Advanced Propulsion Centre3 papers (2022–2023)Xinwei Han · Zhengzhou University3 papers (2021–2025)Lifeng Li · Genesis Medical Center3 papers (2021–2023)Xing Zhou · China Pharmaceutical University3 papers (2024–2025) · 3 papers (2024–2025) · 3 papers (2024–2025)José M. Vicencio · AstraZeneca (United Kingdom)3 papers (2022–2023)Benyu Liu · Tianjin University of Traditional Chinese Medicine3 papers (2024–2025)Dan Shan · University of Alabama at Birmingham3 papers (2024–2025)Teng Pan · Hebei Medical University3 papers (2022–2023)Richard Beatson · King's College London3 papers (2021–2025)Peng Luo · Harbin University of Science and Technology3 papers (2024–2025)Zhongyuan Huang · Fudan University2 papers (2022–2023)Boyang Mao · University of Manchester2 papers (2022–2023)Jincan Zhang · Shandong University2 papers (2022–2023)